Home
Sessions
PQA 07: Head and Neck Cancer, Lung Cancer/Thoracic Malignancies, and Nursing and Supportive Care
Survival Outcomes in Inoperable Stage III NSCLC: Comparing Immunotherapy (+/- Chemotherapy) followed by Radiotherapy vs. Standard of Care Chemoradiation Followed by Adjuvant Durvalumab

Sep 29

PQA 07 - PQA 07: Head and Neck Cancer, Lung Cancer/Thoracic Malignancies, and Nursing and Supportive Care

3553 - Survival Outcomes in Inoperable Stage III NSCLC: Comparing Immunotherapy (+/- Chemotherapy) followed by Radiotherapy vs. Standard of Care Chemoradiation Followed by Adjuvant Durvalumab

03:45pm - 05:00pm ET

Presenter(s)

Mary Mahoney, MD - Fox Chase Cancer Center, Philadelphia, PA